focus -WSS

focus

author：hotspot 2025-09-27 22:56:59 - browse：1645

U.S. Sen. Bernie Sanders sets his hands on two chairs as two people set up a board displaying a "price of drugs" chart behind him — politics coverage from STAT — Sen. Bernie Sanders has used his leadership of a Senate committee to pressure drugmakers to lower their prices. Kevin Dietsch/Getty Images

WASHINGTON — Bernie Sanders is figuring out just how far bullying drugmakers can take him.

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing. After a few victories he’s claimed — experts say some credit is deserved, but the full story is a bit more complicated — he’s now progressed to demanding that Novo Nordisk cut its price for its novel, wildly popular diabetes and weight-loss drugs.

Sanders (I-Vt.) is testing the limits of the powers of a Senate chairman with little hope of advancing his policy agenda legislatively. He’s threatened subpoenas, held a prominent nominee hostage, and initiated investigations to get his way. It’s a sharp departure from the modest, bipartisan ambitions that more disciplined, discreet leaders of the committee have taken in years past, and sets the bar for how much can be accomplished using the full extent of the bully pulpit.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Shionogi licenses Pompe disease therapy from Maze Therapeutics

Wikipedia

WSS

First recipient of genetically engineered pig kidney has died

Trump got a 'target letter.' What is one and what does it mean?

Study: Adult vaccinations pay for themselves in societal benefits

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

'Reaching a detente': STAT's Helen Branswell on covering Covid

Resistance to cancer drugs: A new genetic explanation

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

Making AI in medicine accessible to smaller, and rural hospitals

Medical records are filled with copy

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

New air purifier tech could be key to improving indoor air quality

CDC wastewater surveillance dashboard to track bird flu hotspots

Malaria cases in Florida and Texas: Here’s what you need to know

First recipient of genetically engineered pig kidney has died

Malaria cases in Florida and Texas: Here’s what you need to know

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

leisure time

Researchers on aging grapple with how to calculate biological age

Trump got a 'target letter.' What is one and what does it mean?

Researchers separate signal from noise in heart wearable data

Researchers separate signal from noise in heart wearable data

After gene therapy, two congenitally deaf children hear for the first time

Why the Crimean Bridge is key to Russia's war in Ukraine

explore

explore

Wikipedia

knowledge